{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:13:12Z","timestamp":1792411992087,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1124\/mol.112.082347","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T04:30:27Z","timestamp":1365741027000},"page":"12-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells"],"prefix":"10.1016","volume":"84","author":[{"given":"Lars Petter","family":"Jordheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled H.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Heinrich-Balard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Laure","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Cros-Perrial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Bouledrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"El Sabeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Perez-Pineiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Tuszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dumontet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.082347_bib1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10822-007-9159-2","article-title":"An improved relaxed complex scheme for receptor flexibility in computer-aided drug design","volume":"22","author":"Amaro","year":"2008","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/mol.112.082347_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dnarep.2010.03.010","article-title":"Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells","volume":"9","author":"Arora","year":"2010","journal-title":"DNA Repair (Amst)"},{"key":"10.1124\/mol.112.082347_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.21567","article-title":"Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy","volume":"218","author":"Azmi","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.112.082347_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jmgm.2009.12.003","article-title":"Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2\/MDMX interactions","volume":"28","author":"Barakat","year":"2010","journal-title":"J Mol Graph Model"},{"key":"10.1124\/mol.112.082347_bib5","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jmgm.2010.12.003","article-title":"Relaxed complex scheme suggests novel inhibitors for the lyase activity of DNA polymerase beta","volume":"29","author":"Barakat","year":"2011","journal-title":"J Mol Graph Model"},{"key":"10.1124\/mol.112.082347_bib6","doi-asserted-by":"crossref","first-page":"e51329","DOI":"10.1371\/journal.pone.0051329","article-title":"Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction","volume":"7","author":"Barakat","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/mol.112.082347_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jmgm.2009.04.009","article-title":"Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach","volume":"28","author":"Barakat","year":"2009","journal-title":"J Mol Graph Model"},{"key":"10.1124\/mol.112.082347_bib46","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.112.082347_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1124\/mol.112.082347_bib9","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1172\/JCI42771","article-title":"Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation","volume":"120","author":"Coste","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.112.082347_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00685597","article-title":"Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin","volume":"30","author":"Damia","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Web Server issue","key":"10.1124\/mol.112.082347_bib11","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.112.082347_bib12","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/jm991174y","article-title":"Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels","volume":"43","author":"Frostell-Karlsson","year":"2000","journal-title":"J Med Chem"},{"key":"10.1124\/mol.112.082347_bib13","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1124\/mol.112.082347_bib14","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity: a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1124\/mol.112.082347_bib15","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1158\/1078-0432.CCR-10-0593","article-title":"Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer","volume":"16","author":"Hsu","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.112.082347_bib16","doi-asserted-by":"crossref","first-page":"e25164","DOI":"10.1371\/journal.pone.0025164","article-title":"Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations","volume":"6","author":"Hubner","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1124\/mol.112.082347_bib17","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, Recognition, and Processing of Cisplatin-DNA Adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1124\/mol.112.082347_bib18","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/1535-7163.MCT-05-0121","article-title":"Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells","volume":"4","author":"Jordheim","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.112.082347_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/jcph.1999.6201","article-title":"NAMD2: Greater Scalability for Parallel Molecular Dynamics","volume":"151","author":"Kale","year":"1999","journal-title":"J Comput Phys"},{"key":"10.1124\/mol.112.082347_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc Chem Res"},{"key":"10.1124\/mol.112.082347_bib21","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/jm049081q","article-title":"Validation and use of the MM-PBSA approach for drug discovery","volume":"48","author":"Kuhn","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/mol.112.082347_bib22","series-title":"Principles of fluorescence spectroscopy","author":"Lakowicz","year":"1999"},{"key":"10.1124\/mol.112.082347_bib23","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1021\/ja0260162","article-title":"Computational drug design accommodating receptor flexibility: the relaxed complex scheme","volume":"124","author":"Lin","year":"2002","journal-title":"J Am Chem Soc"},{"key":"10.1124\/mol.112.082347_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1470-2045(01)00454-5","article-title":"Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance","volume":"2","author":"McHugh","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1124\/mol.112.082347_bib25","doi-asserted-by":"crossref","first-page":"9990","DOI":"10.1093\/nar\/gks818","article-title":"DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy","volume":"40","author":"McNeil","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.112.082347_bib26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.112.082347_bib27","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1128\/MCB.24.13.5776-5787.2004","article-title":"The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks","volume":"24","author":"Niedernhofer","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.112.082347_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00018-009-8737-y","article-title":"DNA repair in mammalian cells : Nucleotide excision repair: variations on versatility","volume":"66","author":"Nouspikel","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/mol.112.082347_bib29","first-page":"724","article-title":"Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo","volume":"54","author":"O\u2019Dwyer","year":"1994","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.082347_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cyto.b.20450","article-title":"Kinetics of H2AX phosphorylation after exposure to cisplatin","volume":"76","author":"Olive","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1124\/mol.112.082347_bib45","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1124\/mol.112.082347_bib31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/em.20583","article-title":"Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair","volume":"51","author":"Rahn","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"10.1124\/mol.112.082347_bib32","doi-asserted-by":"crossref","first-page":"17079","DOI":"10.1073\/pnas.0806092105","article-title":"High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs","volume":"105","author":"Rottenberg","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.082347_bib33","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1158\/1078-0432.CCR-07-5136","article-title":"Targeting the MDM2-p53 interaction for cancer therapy","volume":"14","author":"Shangary","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.112.082347_bib34","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/ct700119m","article-title":"Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms","volume":"3","author":"Shao","year":"2007","journal-title":"J Chem Theory Comput"},{"key":"10.1124\/mol.112.082347_bib35","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.str.2005.08.014","article-title":"The structure of the human ERCC1\/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair","volume":"13","author":"Tripsianes","year":"2005","journal-title":"Structure"},{"key":"10.1124\/mol.112.082347_bib36","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/sj.emboj.7601894","article-title":"Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA","volume":"26","author":"Tsodikov","year":"2007","journal-title":"EMBO J"},{"key":"10.1124\/mol.112.082347_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1476-4598-9-248","article-title":"Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression","volume":"9","author":"Usanova","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1124\/mol.112.082347_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molstruc.2011.05.023","article-title":"Fluorescence quenching and ligand binding: A critical discussion of a popular methodology","volume":"998","author":"van de Weert","year":"2011","journal-title":"J Mol Struct"},{"key":"10.1124\/mol.112.082347_bib39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/em.20569","article-title":"Mammalian nucleotide excision repair proteins and interstrand crosslink repair","volume":"51","author":"Wood","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"10.1124\/mol.112.082347_bib40","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1158\/0008-5472.CAN-04-0348","article-title":"Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents","volume":"64","author":"Youn","year":"2004","journal-title":"Cancer Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24037350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24037350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.082347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:14:30Z","timestamp":1739963670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24037350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0026895X24037350"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.082347","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.082347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}